French AI biotech unicorn Owkin has launched a €33 million AI-powered precision medicine project for cancer diagnosis and treatment
Stroke, Myocardial Infarction, and Pulmonary Embolism after Bivalent Booster — [A French study, reassures the continued use of this bivalent vaccine]
Read More Autonomous AI — too good to be true? Oxipit have truly made a bold step forward, daring to go beyond where others have yet to tread. The… byJoaquim Cardoso26 de abril de 2022
